administered dose for drugs dosed per kg body weight [Design Issues]

posted by luvblooms  – India, 2014-08-12 08:28 (4337 d 20:59 ago) – Posting: # 13364
Views: 9,409

Hi Helmut


❝ I think that EMA’s draft guidance can easily be misinterpreted (see my remarks at the end of this post). Maybe the guidance’s wording is just ambiguous. The 500 mg strength is OK, but should not be interpreted as the suitable dose – which should still be calculated according to the common poso­logy.


Totally agreed to the point raised by you. Also the study has to be done in patients thus using just 500 mg (where as the dose based on BSA lies in 1500-2500 mg) is also not ethically right. We have already asked for clarification on the same from EMEA. Lets see if we can get a reply.

IF the study has to be done on healthy volunteers (after regulatory consultation) using 500 mg should be ok.
Remember Imatinib guidance

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
333 visitors (0 registered, 333 guests [including 26 identified bots]).
Forum time: 05:27 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5